Fosun International Ltd purchased a new stake in shares of Clorox Co (NYSE:CLX) in the third quarter, HoldingsChannel.com reports. The institutional investor purchased 6,300 shares of the company’s stock, valued at approximately $940,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in CLX. Parnassus Investments CA increased its stake in Clorox by 1.6% in the 2nd quarter. Parnassus Investments CA now owns 4,711,970 shares of the company’s stock worth $637,294,000 after purchasing an additional 76,149 shares during the period. Macquarie Group Ltd. increased its stake in Clorox by 437,400.0% in the 2nd quarter. Macquarie Group Ltd. now owns 1,750,000 shares of the company’s stock worth $236,688,000 after purchasing an additional 1,749,600 shares during the period. Bank of New York Mellon Corp increased its stake in Clorox by 15.1% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,664,803 shares of the company’s stock worth $250,403,000 after purchasing an additional 218,364 shares during the period. Schroder Investment Management Group increased its stake in Clorox by 57.0% in the 2nd quarter. Schroder Investment Management Group now owns 1,506,358 shares of the company’s stock worth $201,641,000 after purchasing an additional 547,070 shares during the period. Finally, Morgan Stanley increased its stake in Clorox by 44.2% in the 2nd quarter. Morgan Stanley now owns 1,101,380 shares of the company’s stock worth $148,962,000 after purchasing an additional 337,621 shares during the period. 76.33% of the stock is currently owned by institutional investors.

CLX opened at $160.41 on Wednesday. The company has a debt-to-equity ratio of 3.38, a quick ratio of 0.65 and a current ratio of 1.07. Clorox Co has a 52-week low of $113.57 and a 52-week high of $163.44. The company has a market cap of $20.73 billion, a PE ratio of 25.62, a price-to-earnings-growth ratio of 3.99 and a beta of 0.28.

Clorox (NYSE:CLX) last posted its earnings results on Wednesday, October 31st. The company reported $1.62 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.59 by $0.03. Clorox had a return on equity of 102.65% and a net margin of 13.59%. The firm had revenue of $1.56 billion for the quarter, compared to analysts’ expectations of $1.53 billion. During the same period in the previous year, the firm earned $1.46 earnings per share. The business’s revenue was up 4.2% compared to the same quarter last year. As a group, equities analysts anticipate that Clorox Co will post 6.31 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 8th. Stockholders of record on Wednesday, January 23rd will be paid a dividend of $0.96 per share. The ex-dividend date is Tuesday, January 22nd. This represents a $3.84 annualized dividend and a dividend yield of 2.39%. Clorox’s dividend payout ratio (DPR) is presently 61.34%.

In related news, SVP Michael R. Costello sold 6,882 shares of Clorox stock in a transaction that occurred on Thursday, November 15th. The stock was sold at an average price of $160.08, for a total transaction of $1,101,670.56. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, COO Dawn C. Willoughby sold 54,205 shares of Clorox stock in a transaction that occurred on Tuesday, November 6th. The shares were sold at an average price of $157.39, for a total value of $8,531,324.95. Following the sale, the chief operating officer now owns 37,044 shares in the company, valued at $5,830,355.16. The disclosure for this sale can be found here. Insiders have sold 93,970 shares of company stock worth $14,567,178 over the last three months. Insiders own 1.40% of the company’s stock.

CLX has been the topic of a number of analyst reports. Zacks Investment Research cut Clorox from a “buy” rating to a “hold” rating in a research note on Friday, October 5th. BMO Capital Markets lifted their price target on Clorox from $153.00 to $165.00 and gave the stock a “buy” rating in a research note on Friday, November 2nd. ValuEngine raised Clorox from a “hold” rating to a “buy” rating in a research note on Saturday, September 22nd. Citigroup boosted their target price on Clorox from $149.00 to $153.00 and gave the company a “neutral” rating in a research note on Friday, November 2nd. Finally, Argus raised Clorox from a “hold” rating to a “buy” rating and set a $175.00 target price on the stock in a research note on Tuesday, September 25th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $142.79.

ILLEGAL ACTIVITY WARNING: This article was first posted by Daily Political and is the sole property of of Daily Political. If you are reading this article on another domain, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this article can be read at https://www.dailypolitical.com/2018/11/21/fosun-international-ltd-invests-940000-in-clorox-co-clx.html.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Featured Story: What is a Stop Order?

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.